The program is being developed for three main purposes:
A. Dose assessment after acute whole body exposure.
B. Dose assessment in partial body exposure
C. Dose assessment after protracted and fractioned exposure
The following DNA lesions can be investigated with the help of the program:
B. γ-H2AX foci
D. PCC fragments
It is planned to include Comet assays as well RICA assays in the future.
Be the first to post a review of Dosematic3!